PhorMed Inc Launches New Regulation CF Equity Crowdfunding Campaign on WeFunder

LOS ANGELES, Feb. 22, 2024 /PRNewswire/ — PhorMed Inc. (PhorMed or Company) recently filed a Form C for the purpose of launching a Regulatory CF, equity crowdfunding campaign, on the platform WeFunder at PhorMed is a clinical stage biopharmaceutical company…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks